本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Black Diamond Therapeutics, Inc.

1.88
+0.16009.30%
盤後1.81-0.0700-3.72%19:59 EDT
成交量:2,240.47萬
成交額:4,339.19萬
市值:1.07億
市盈率:-1.48
高:2.10
開:1.83
低:1.75
收:1.72
資料載入中...

公司資料

公司名字:
Black Diamond Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2014
員工人數:
24
公司地址:
One Main Street,14th Floor,Cambridge,Massachusetts,United States
郵編:
02142
電話:
傳真:
- -
簡介:
Black Diamond Therapeutics, Inc.於2014年12月在特拉華州成立。該公司是一家臨床階段的腫瘤學公司,專註於開發用於治療基因定義腫瘤患者的MasterKey療法。該公司的目標是基因定義癌症患者中不存在藥物的致癌驅動基因突變。

董事

名稱
職位
Bradley Bolzon
Director and Chairman of the Board of Director
David M. Epstein
President, Chief Executive Officer and Director
Alexander Mayweg
Director
Ali Behbahani
Director
Garry E. Menzel
Director
Rajeev Shah
Director
Samarth Kulkarni
Director

股東

名稱
職位
David M. Epstein
President, Chief Executive Officer and Director
Brent Hatzis Schoch
Chief Operating Officer and General Counsel
Karsten Witt
Senior Vice President, Clinical Development
Thomas Leggett
Chief Financial Officer
Christopher D. Roberts
Chief Scientific Officer
Elizabeth Buck
Executive Vice President, Discovery and Translational Services